Grimes & Company’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$303K Sell
20,987
-3,396
-14% -$48.7K 0.01% 354
2025
Q4
$347K Hold
24,383
0.01% 360
2025
Q3
$192K Buy
24,383
+456
+2% +$3.25K ﹤0.01% 441
2025
Q2
$137K Buy
23,927
+717
+3% +$4.63K ﹤0.01% 406
2025
Q1
$189K Sell
23,210
-1,060
-4% -$9.81K 0.01% 357
2024
Q4
$229K Hold
24,270
0.01% 348
2024
Q3
$259K Hold
24,270
0.01% 318
2024
Q2
$241K Buy
24,270
+47
+0.2% +$482 0.01% 305
2024
Q1
$285K Sell
24,223
-145
-0.6% -$1.85K 0.01% 275
2023
Q4
$346K Sell
24,368
-283
-1% -$3.21K 0.01% 251
2023
Q3
$300K Buy
24,651
+412
+2% +$5.32K 0.01% 242
2023
Q2
$304K Buy
24,239
+43
+0.2% +$510 0.01% 241
2023
Q1
$268K Buy
+24,196
New +$298K 0.01% 249

Other funds holding FOLD